APAC Radiation Dose Management Market

APAC Radiation Dose Management Market Size (2024 to 2029)

The size of the radiation dose management market is estimated to be growing at a CAGR of 16.21% from 2024 to 2029 and worth USD 157.61 million by 2029 from USD 74.36 million in 2024.

An increase in radiation use involving mammography, computed tomography (CT), radiotherapy, nuclear medicine, fluoroscopy, interventional imaging, and others are expected to drive the APAC radiation dose management market during the forecast period. In addition, due to the increase in the harmful effects of radiation in patients and the high risk of an occupational hazard, the adoption rate of radiation dose management in hospitals, clinics, research centers, diagnostic centers, and academic institutions have dramatically increased.

Over the past several years, there has been an increase in radiation therapy and nuclear medicine due to cancer's increased prevalence. Likewise, a very high dose of radiation to patients over a long period may increase cancer risk among exposed people. As reported by the World Nuclear Association, more than 10,000 hospitals worldwide use radioisotopes as a diagnostic medicine, which is almost 90%. According to the World Health Organization, nearly 70% of cancer deaths occur in low- and middle-income countries, especially in the APAC region. According to GLOBOCAN 2018 estimates, about 4,285,033 new cancer cases were diagnosed in China, including 2,366,010 males and 1,919,023 females. The incidence rates for all cancers were 301.1 in males and 201.7 in females per 100,000.

There have been increased CT and MRI cases as diagnostics procedures during 2020-2022. Moreover, many hospitals and imaging centers are increasingly adopting newer dose reduction technology with high-end CT systems. Additionally, strict guidelines are followed for physicians to protect themselves with self-monitoring badges such as dosimeters and TLD badges. These factors will support the APAC radiation dose management market during the analysis period.

However, despite the various ill-effects of radiation and isotope application over-exposure, several hospitals and clinics lack adequate radiation dose management systems. Furthermore, there are no government-defined standards for radiation dose management for all radiology procedures in the APAC region. In the absence of standardized protocols, technicians, doctors, and patients face the risk of radiation exposure. In addition, many medical facilities in underdeveloped or developing economies face the problem of high maintenance costs, lack of knowledge among technicians and physicians, and poor healthcare infrastructure. All these factors are significant impediments to the growth of the APAC radiation dose management market.

This report on the APAC radiation dose management market has been segmented and sub-segmented into the following categories.

By Product and Services:

• Radiation Dose Management Solutions 
  • Standalone Solutions
  • Integrated Solutions
• Radiation Dose Management Services
  • Support & Maintenance Services
  • Implementation & Integration Services
  • Consulting Services
  • Education & Training Services

By Technology:

• Computed Tomography 
• Fluoroscopy & Interventional Imaging 
• Radiography & Mammography
• Nuclear Medicine

By Application:

• Oncology
• Cardiology
• Orthopedic Applications
• Other Application

By End-User:

• Hospitals 
• Small Hospitals
• Large Hospitals
• Ambulatory Care Settings
• Other End Users

By Country:

• India
• China
• Japan
• South Korea
• Australia
• New Zealand
• Thailand
• Malaysia
• Vietnam
• Philippines
• Indonesia
• Singapore
• Rest of APAC

In 2023, the regional markets in China and Japan had dominated the APAC radiation dose management market and will continue with the same trend over the following years. Several factors such as the increasing investments from government entities and the private sector, the strong demand for the adoption of IT technologies in the health care industry, the rapid growth of medical tourism, the improvement of health infrastructure, and the increase in the number of people suffering from diseases, especially the senior population.

However, the regional market in India is predicted to have the highest CAGR among all other regional markets, which can be attributed to the presence of a large number of patients, increased patient awareness, a growing number of multi-specialty hospitals, and the popularity of medical tourism in this region.

KEY MARKET PLAYERS:

Bayer AG, Mckesson Corporation, AGFA Healthcare, GE Healthcare Ltd., Sectra Medical Systems GmbH, Fujifilm Holdings Corporation, PACS Health LLC, Koninklijke Philips N.V., Siemens Healthcare Diagnostics Inc., Novarad Corporation, and Toshiba Medical Systems Corporation are a few of the notable players in the APAC radiation dose management market.